Jean-Baptiste Thibert: Protecting Fundamental Human Rights to Improve Patient Access and Donor Health
Jean-Baptiste Thibert, Medical and Biology Director at EFS, shared a post on LinkedIn recent article he and his colleagues co-authored, adding:
“Excited to share our latest collaborative work on protecting fundamental human rights, thereby improving both patient access to plasma-derived therapies and donor health protection.
Patient access to plasma-derived medicinal products and blood donor protection are challenges that are currently hard to meet and often presented like mutually exclusive choices.
We show how advantageous it could be to reposition the fundamental right to health protection as an input parameter for decisions on the transfusion and plasma supply chain.
Placing both patients and donors under the umbrella of fundamental human rights allows to act not as if a choice has to be made between patients and donors, but in ways that protect them both.”
Katja van den Hurk, Head of Donor Studies and Senior Epidemiologist/Principal Investigator at Sanquin, Professor of Donor Health at University of Amsterdam, shared this post on LinkedIn, adding:
“Happy to see this collaborative work published!
Our paper discusses how placing patients and donors under the same human-rights framework can help address challenges in plasma supply; supporting both access to plasma-derived medicinal products and donor health protection.”
Title: Protection of fundamental human rights by improving patient access to plasma-derived therapies and donor health protection
Authors: Jean-Baptiste Thibert, Leni von Bonsdorff, Jean-Philippe Plançon, Vincenzo de Angelis, Cynthia So-Osman, Christian Erikstrup, Pierre Tiberghien, Katja van den Hurk
Read the Full Article on Vox Sanguinis
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 12, 2026, 12:04Yazan Abou-Ismail: Pleasure Discussing Factor 11 Inhibitors with Nashwa Abdulsalam at Heart Rhythm TV
-
Nov 12, 2026, 11:57Javed Anees: Asundexian – A New Era in Secondary Stroke Prevention
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?
-
Nov 12, 2026, 10:21Aseem Kumar Tiwari: The Molecular Dimension of HLA Matching
-
Nov 12, 2026, 10:18Sarah Connolly: Developing Advanced Haematology Services in Cancer Care
-
Nov 12, 2026, 10:13Carlos Esteban Gasko: Restrictive Transfusion in Critical Care
-
Nov 12, 2026, 10:07Samin Mohsenian: Advancing Care in Rare Bleeding Disorders
-
Nov 12, 2026, 10:03Influenza Vaccination in Patients With ITP – ITP Support Association